PALISADE BIO, INC. Other Current Liabilities
PALISADE BIO, INC. (PALI) had Other Current Liabilities of $19.54 thousand as of 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2019-08-14
- 2019-06-30: Other Liabilities, Current $19.54K.
- 2019-03-31: Other Liabilities, Current $126.93K.
- 2018-12-31: Other Liabilities, Current $218.60K.
- 2018-09-30: Other Liabilities, Current $348.93K.
| Period end | Other Liabilities, Current |
|---|---|
| 2019-06-30 | $19.54K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $126.93K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $218.60K 10-Q · filed 2019-08-14 |
| 2018-09-30 | $348.93K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $52.93K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $109.27K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $220.88K 10-K · filed 2019-03-22 |
| 2017-09-30 | $358.04K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $67.99K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $349.09K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $430.74K 10-K · filed 2018-04-02 |
| 2016-09-30 | $538.35K 10-Q · filed 2016-11-08 |
| 2016-06-30 | $204.46K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $241.01K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $263.10K 10-K · filed 2017-03-23 |
| 2015-09-30 | $207.29K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $148.54K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $52.86K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $126.75K 10-K · filed 2016-03-14 |
| 2014-09-30 | $202.38K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $13.14K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $53.28K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $93.43K 10-K · filed 2015-03-16 |
| 2013-09-30 | $174.34K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $10.63K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $42.57K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $90.78K 10-K · filed 2014-03-10 |
| 2012-09-30 | $138.99K 10-Q · filed 2012-11-09 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |